Ane Gerda Zahl Eriksson

  • Senior consultant
  • +47 22 93 44 46

Publications 2019

Eriksson AG, Fallaas Dahl G, Nesbakken AJ, Lund KV, Amant F (2019)
Endometrial cancer during pregnancy: management strategies
Int J Gynecol Cancer, 29 (7), 1221-1224
DOI 10.1136/ijgc-2019-000756, PubMed 31434687

Falconer H, Palsdottir K, Stalberg K, Dahm-Kähler P, Ottander U, Lundin ES, Wijk L, Kimmig R, Jensen PT, Zahl Eriksson AG, Mäenpää J, Persson J, Salehi S (2019)
Robot-assisted approach to cervical cancer (RACC): an international multi-center, open-label randomized controlled trial
Int J Gynecol Cancer, 29 (6), 1072-1076
DOI 10.1136/ijgc-2019-000558, PubMed 31203203

Lecuru FR, McCormack M, Hillemanns P, Anota A, Leitao M, Mathevet P, Zweemer R, Fujiwara K, Zanagnolo V, Zahl Eriksson AG, Hudson E, Ferron G, Plante M (2019)
SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study
Int J Gynecol Cancer, 29 (4), 829-834
DOI 10.1136/ijgc-2019-000332, PubMed 30898938

Publications 2018

Agostini A, Brunetti M, Davidson B, Tropé CG, Eriksson AGZ, Heim S, Panagopoulos I, Micci F (2018)
The microRNA miR-192/215 family is upregulated in mucinous ovarian carcinomas
Sci Rep, 8 (1), 11069
DOI 10.1038/s41598-018-29332-7, PubMed 30038317

Schlappe BA, Weaver AL, Ducie JA, Eriksson AGZ, Dowdy SC, Cliby WA, Glaser GE, Soslow RA, Alektiar KM, Makker V, Abu-Rustum NR, Mariani A, Leitao MM (2018)
Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy
Gynecol Oncol, 151 (2), 235-242
DOI 10.1016/j.ygyno.2018.08.022, PubMed 30177461

Publications 2017

Cowan RA, Eriksson AGZ, Jaber SM, Zhou Q, Iasonos A, Zivanovic O, Leitao MM, Abu-Rustum NR, Chi DS, Gardner GJ (2017)
A comparative analysis of prediction models for complete gross resection in secondary cytoreductive surgery for ovarian cancer
Gynecol Oncol, 145 (2), 230-235
DOI 10.1016/j.ygyno.2017.02.010, PubMed 28285846

Ducie JA, Eriksson AGZ, Ali N, McGree ME, Weaver AL, Bogani G, Cliby WA, Dowdy SC, Bakkum-Gamez JN, Soslow RA, Keeney GL, Abu-Rustum NR, Mariani A, Leitao MM (2017)
Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease
Gynecol Oncol, 147 (3), 541-548
DOI 10.1016/j.ygyno.2017.09.030, PubMed 28965698

Eriksson AG, Beavis A, Soslow RA, Zhou Q, Abu-Rustum NR, Gardner GJ, Zivanovic O, Long Roche K, Sonoda Y, Leitao MM, Jewell EL (2017)
A Comparison of the Detection of Sentinel Lymph Nodes Using Indocyanine Green and Near-Infrared Fluorescence Imaging Versus Blue Dye During Robotic Surgery in Uterine Cancer
Int J Gynecol Cancer, 27 (4), 743-747
DOI 10.1097/IGC.0000000000000959, PubMed 28375931

Eriksson AGZ, Graul A, Yu MC, Halko A, Chi DS, Zivanovic O, Gardner GJ, Sonoda Y, Barakat RR, Abu-Rustum NR, Leitao MM (2017)
Minimal access surgery compared to laparotomy for secondary surgical cytoreduction in patients with recurrent ovarian carcinoma: Perioperative and oncologic outcomes
Gynecol Oncol, 146 (2), 263-267
DOI 10.1016/j.ygyno.2017.05.022, PubMed 28527673

Publications 2016

Eriksson AG, Montovano M, Beavis A, Soslow RA, Zhou Q, Abu-Rustum NR, Gardner GJ, Zivanovic O, Barakat RR, Brown CL, Levine DA, Sonoda Y, Leitao MM, Jewell EL (2016)
Impact of Obesity on Sentinel Lymph Node Mapping in Patients with Newly Diagnosed Uterine Cancer Undergoing Robotic Surgery
Ann Surg Oncol, 23 (8), 2522-8
DOI 10.1245/s10434-016-5134-2, PubMed 26905542

Leitao MM, Narain WR, Boccamazzo D, Sioulas V, Cassella D, Ducie JA, Eriksson AG, Sonoda Y, Chi DS, Brown CL, Levine DA, Jewell EL, Zivanovic O, Barakat RR, Abu-Rustum NR, Gardner GJ (2016)
Impact of Robotic Platforms on Surgical Approach and Costs in the Management of Morbidly Obese Patients with Newly Diagnosed Uterine Cancer
Ann Surg Oncol, 23 (7), 2192-8
DOI 10.1245/s10434-015-5062-6, PubMed 26744108

Mueller JJ, Zhou QC, Iasonos A, O'Cearbhaill RE, Alvi FA, El Haraki A, Eriksson AG, Gardner GJ, Sonoda Y, Levine DA, Aghajanian C, Chi DS, Abu-Rustum NR, Zivanovic O (2016)
Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center
Gynecol Oncol, 140 (3), 436-42
DOI 10.1016/j.ygyno.2016.01.008, PubMed 26777991

Publications 2015

St Clair CM, Eriksson AG, Ducie JA, Jewell EL, Alektiar KM, Hensley ML, Soslow RA, Abu-Rustum NR, Leitao MM (2015)
Low-Volume Lymph Node Metastasis Discovered During Sentinel Lymph Node Mapping for Endometrial Carcinoma
Ann Surg Oncol, 23 (5), 1653-9
DOI 10.1245/s10434-015-5040-z, PubMed 26714954

Zahl Eriksson AG, Ducie J, Ali N, McGree ME, Weaver AL, Bogani G, Cliby WA, Dowdy SC, Bakkum-Gamez JN, Abu-Rustum NR, Mariani A, Leitao MM (2015)
Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion
Gynecol Oncol, 140 (3), 394-9
DOI 10.1016/j.ygyno.2015.12.028, PubMed 26747778

Publications 2011

Staff AC, Trovik J, Eriksson AG, Wik E, Wollert KC, Kempf T, Salvesen HB (2011)
Elevated plasma growth differentiation factor-15 correlates with lymph node metastases and poor survival in endometrial cancer
Clin Cancer Res, 17 (14), 4825-33
DOI 10.1158/1078-0432.CCR-11-0715, PubMed 21616994

Publications 2002

Blaas HG, Eriksson AG, Salvesen KA, Isaksen CV, Christensen B, Møllerløkken G, Eik-Nes SH (2002)
Brains and faces in holoprosencephaly: pre- and postnatal description of 30 cases
Ultrasound Obstet Gynecol, 19 (1), 24-38
DOI 10.1046/j.0960-7692.2001.00154.x, PubMed 11851965

Page visits: 1031